Mechanism | Cancers | Regulator | TXNDC5 expression | Effect | Result | Ref |
---|---|---|---|---|---|---|
Regulate cell cycle | GC | – | Up | – | Increase percentage of cells in G2/M phase | [25] |
GC | – | Silence | – | Increase percentage of cells in 0/G1 phase | [25] | |
CRPC | – | Up | – | Cause cell cycle disorders between G2/M and S phases | [29] | |
Protect cells from oxidative stress | CRC | Hif-1α | Up | Inhibit ROS/ER stress | Promote the reproduction and survival of cells under hypoxia | [28] |
CRPC | Hif-1α& miR-200b | Up | Interact with AR and enhance its transcriptional activity | promote the progression of CRPC | [29] | |
Signalling pathway | CC | – | Inhibition | Increase expression of SERPINF1 and TRAF1 | Inhibit angioplasty, cell proliferation and migration | [26] |
LC | – | Up | Combine with Srx | Promote cell proliferation and metastasis |